<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib0190">
 <label>38</label>
 <element-citation publication-type="book" id="sbref0190">
  <person-group person-group-type="author">
   <name>
    <surname>Belhadi</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Peiffer-Smadja</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Lescure</surname>
    <given-names>F.-X.-X.</given-names>
   </name>
   <name>
    <surname>Yazdanpanah</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Mentré</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Laouénan</surname>
    <given-names>C.</given-names>
   </name>
  </person-group>
  <chapter-title>A brief review of antiviral drugs evaluated in registered clinical trials for COVID-19</chapter-title>
  <year>2020</year>
  <publisher-name>medRxiv</publisher-name>
  <pub-id pub-id-type="doi">10.1101/2020.03.18.20038190</pub-id>
  <comment>2020.03.18.20038190</comment>
 </element-citation>
</ref>
